ABSTRACT
A key methodological challenge for genome wide association studies is how to leverage haplotype diversity and allelic heterogeneity to improve trait association power, especially in noncoding regions where it is difficult to predict variant impacts and define functional units for variant aggregation. Genealogy-based association methods have the potential to bridge this gap by testing combinations of common and rare haplotypes based purely on their ancestral relationships. In parallel work we developed an efficient local ancestry inference engine and a novel statistical method (LOCATER) for combining signals present on different branches of a locus specific haplotype tree. Here, we developed a genome-wide LOCATER analysis pipeline and applied it to a genome sequencing study of 6,795 Finnish individuals with 101 cardiometabolic traits and 18.9 million autosomal variants. We identified 351 significant trait associations at 47 genomic loci and found that LOCATER boosted single marker test (SMT) association power at 5 loci by combining independent signals from distinct alleles. LOCATER successfully recovered known quantitative trait loci not found by SMT, including LIPG, recovered known allelic heterogeneity at the APOE/C1/C4/C2 gene cluster, and suggested one novel association. We find that confounders have a more pronounced effect on genealogy-based methods than SMT; we propose a new randomization approach and a general method for genomic control to eliminate their effects. This study demonstrates that genealogy-based methods such as LOCATER excel when multiple causal variants are present and suggests that their application to larger and more diverse cohorts will be fruitful.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RC and XW were supported by NIH grants R01HG013371 and UM1HG008853 to IH. LJMA was partially supported by the EPSRC research grant "PINCODE", reference EP/X028100/1, and UKRI grant, "OCEAN", reference EP/Y014650/1. DS was supported by BBSRC research grant BB/S001824/1. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at dbGaP (accession number for genotype data: phs001579; phenotype data: phs000752).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
DATA AND CODE AVAILABILITY
Data are available from dbGaP (accession number for genotype data: phs001579; phenotype data: phs000752). The code used to perform the analyses in this paper is available on a GitHub page: https://github.com/Xinxin-Wang-0128/LOCATER_real_data_vignette. The link to the LOCATER software will be public once the corresponding study is published.
